drugset / Trial / NCT05664555

Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study)

NCT05664555

Phase 4 Completed 144 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

This study aims to compare the efficacy and safety of fluorescein angiography using 1mL versus 3mL of 10% fluorescein dye.

Timeline

Start
2023-02-01
Primary completion
2024-03-31
Completion
2024-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluorescein Diagnostic / imaging agent 100 mg Intravenous
Subject Fluorescein Diagnostic / imaging agent 300 mg Intravenous

Indications